Estrella Immunopharma, INC. (ESLAW) SEC Filings — 2025
15 SEC filings for Estrella Immunopharma, INC. (ESLAW) in 2025.
Filings
- Estrella Immunopharma Registers 2.5M Shares for Resale Amid Rising Losses — S-1 · Dec 22, 2025
- Estrella Immunopharma Files 8-K — 8-K · Dec 4, 2025
- Estrella Immunopharma's Net Loss Widens 59.6% Amid R&D Surge — 10-Q · Nov 12, 2025
- Estrella Immunopharma, INC. 8-K Filing — 8-K · Nov 6, 2025
- Estrella Immunopharma Files 8-K for Other Events — 8-K · Sep 29, 2025
- Estrella Immunopharma Reports Director/Officer Changes — 8-K · Sep 26, 2025
- Estrella Immunopharma's Net Loss Widens 73% Amid R&D Surge — 10-Q · Aug 12, 2025
- Estrella Immunopharma Faces Delisting Concerns — 8-K · Aug 7, 2025
- Estrella Immunopharma Files 8-K — 8-K · Jun 5, 2025
- Estrella Immunopharma Files 8-K on Key Agreements — 8-K · Jun 3, 2025
- Estrella Immunopharma Files 8-K — 8-K · May 29, 2025
- Estrella Immunopharma Files Q1 2025 10-Q — 10-Q · May 14, 2025
- Estrella Immunopharma Faces Delisting Concerns — 8-K · May 2, 2025
- Estrella Immunopharma Files 8-K — 8-K · Feb 21, 2025
- Estrella Immunopharma Files 8-K — 8-K · Feb 20, 2025